Abstract: The present invention describes methods of treating cellulosic materials with a composition that provides increased hydrophobicity to such materials without sacrificing the biodegradability thereof. The methods as disclosed provide for esterification of available hydroxyl groups on cellulosic materials, where such hydroxyl groups are “masked” by bulky organic chains, including that the disclosure provides products made by such methods. The materials thus treated display higher hydrophobicity, barrier function, and mechanical properties, and may be used in any application where such features are desired.

Abstract: The invention encompasses a formulation for hair loss prevention comprising a mixture of water and at least one nonpolar aprotic organic solvent and at least one hair loss preventive ingredient known to inhibit the hormonal mechanism underlying androgenetic hair loss and methods of using the same.

Abstract: A formulation for hair loss prevention comprising at least one hair loss preventive ingredient known to inhibit the hormonal mechanism underlying androgenetic hair loss and a mixture of water and at least one aprotic organic solvent capable of solubilizing sebum and allowing the hair loss preventive ingredient to reach the skin and/or hair follicle, and methods of using the same.

Abstract: The present invention describes methods of treating cellulosic materials with a composition that provides increased hydrophobicity to such materials without sacrificing the biodegradability thereof. The methods as disclosed provide for esterification of available hydroxyl groups on cellulosic materials, where such hydroxyl groups are “masked” by bulky organic chains, including that the disclosure provides products made by such methods. The materials thus treated display higher hydrophobicity, barrier function, and mechanical properties, and may be used in any application where such features are desired.

Abstract: This invention relates to pharmaceutical compositions comprising a sulfonated biological precursor of thymidine, such as a precursor of 4-thiothymidine (4-TT), and their use in the photodynamic treatment of skin hyperplasias, including cancer, psoriasis, actinic keratosis and keloids, by topical or systemic administration.

Abstract: This invention relates to pharmaceutical compositions comprising a sulfonated biological precursor of thymidine, such as a precursor of 4-thiothymidine (4-TT), and their use in the photodynamic treatment of skin hyperplasias, including cancer, psoriasis, actinic keratosis and keloids, by topical or systemic administration.